Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVE 2: Telaprevir with Peg-IFN +/- Ribavirin in Hepatitis C
NCT00372385Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Aug 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Aug 2006; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00372385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372385.